Bone loss and the aromatase inhibitors

Lester, J. and Coleman, R. orcid.org/0000-0002-4275-1043 (2005) Bone loss and the aromatase inhibitors. British Journal of Cancer, 93. S16-S22. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2005 Cancer Research UK. This work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
Keywords: aromatase inhibitors; bone loss; tamoxifen; steroidal; nonsteroidal; metastatic breast-cancer; healthy postmenopausal women; fracture intervention trial; randomized controlled-trial; x-ray absorptiometry; first-line therapy; mineral density; vertebral fractures; phase-iii; megestrol-acetate
Dates:
  • Published: 15 August 2005
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 13 Dec 2016 09:55
Last Modified: 13 Dec 2016 10:01
Published Version: http://dx.doi.org/10.1038/sj.bjc.6602691
Status: Published
Publisher: Cancer Research UK
Refereed: Yes
Identification Number: https://doi.org/10.1038/sj.bjc.6602691

Share / Export

Statistics